Spondyloepimetaphyseal dysplasia, Geneviève type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:168454OMIM:610442Q77.7
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spondyloepimetaphyseal dysplasia, Geneviève type (also called SEMD Geneviève type) is an extremely rare genetic bone disorder that affects the growth and development of the spine (spondylo-), the ends of long bones (epiphyseal), and the areas near the growth plates of bones (metaphyseal). This condition belongs to a group of skeletal disorders known as spondyloepimetaphyseal dysplasias. People with this condition typically have short stature, abnormalities of the spine such as flattened vertebrae (platyspondyly), and changes in the shape of the long bones in the arms and legs. Additional features may include joint problems, bowing of the limbs, and distinctive facial features. Because this is such a rare condition, with very few cases described in the medical literature, the full range of symptoms and their severity is not completely understood. There is currently no cure for this condition. Treatment focuses on managing symptoms and may include orthopedic interventions, physical therapy, and monitoring for complications. A team of specialists typically works together to provide the best care for affected individuals. The condition was first described by Dr. Geneviève and colleagues, which is how it received its name.

Also known as:

Key symptoms:

Short statureFlattened bones of the spineAbnormal shape of the ends of long bonesBowing of the legs or armsJoint stiffness or limited range of motionShort limbs compared to the trunkWaddling gait or difficulty walkingDistinctive facial featuresDelayed motor milestonesAbnormal curvature of the spine

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Spondyloepimetaphyseal dysplasia, Geneviève type.

View clinical trials →

No actively recruiting trials found for Spondyloepimetaphyseal dysplasia, Geneviève type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Spondyloepimetaphyseal dysplasia, Geneviève type community →

No specialists are currently listed for Spondyloepimetaphyseal dysplasia, Geneviève type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spondyloepimetaphyseal dysplasia, Geneviève type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spondyloepimetaphyseal dysplasia, Geneviève typeForum →

No community posts yet. Be the first to share your experience with Spondyloepimetaphyseal dysplasia, Geneviève type.

Start the conversation →

Latest news about Spondyloepimetaphyseal dysplasia, Geneviève type

No recent news articles for Spondyloepimetaphyseal dysplasia, Geneviève type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific skeletal changes does my child have, and how might they progress over time?,Is genetic testing available to confirm the exact diagnosis?,What physical therapy or orthopedic treatments would be most helpful right now?,Are there any complications I should watch for as my child grows?,How often should we have follow-up X-rays or specialist visits?,Are there any clinical trials or research studies we could participate in?,What accommodations might my child need at school or in daily life?

Common questions about Spondyloepimetaphyseal dysplasia, Geneviève type

What is Spondyloepimetaphyseal dysplasia, Geneviève type?

Spondyloepimetaphyseal dysplasia, Geneviève type (also called SEMD Geneviève type) is an extremely rare genetic bone disorder that affects the growth and development of the spine (spondylo-), the ends of long bones (epiphyseal), and the areas near the growth plates of bones (metaphyseal). This condition belongs to a group of skeletal disorders known as spondyloepimetaphyseal dysplasias. People with this condition typically have short stature, abnormalities of the spine such as flattened vertebrae (platyspondyly), and changes in the shape of the long bones in the arms and legs. Additional featu

How is Spondyloepimetaphyseal dysplasia, Geneviève type inherited?

Spondyloepimetaphyseal dysplasia, Geneviève type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Spondyloepimetaphyseal dysplasia, Geneviève type typically begin?

Typical onset of Spondyloepimetaphyseal dysplasia, Geneviève type is neonatal. Age of onset can vary across affected individuals.